Suprascapular Neuropathy

Suprascapular neuropathy is compression or traction of the suprascapular nerve along its course over the scapula, producing posterior shoulder pain and weakness of external rotation and/or abduction.

The topic repeatedly describes "deep, poorly-localised posterior shoulder pain" and uses a diagnostic/therapeutic nerve block (the imaging atlas even shows a block ultrasound) — both are explained by the suprascapular nerve's unusual sensory anatomy.

• Predominantly motor, but a major joint-sensory nerve. Beyond supplying supraspinatus and infraspinatus, the suprascapular nerve provides articular (sensory) branches to roughly two-thirds to 70% of the shoulder joint — the posterosuperior glenohumeral capsule, the acromioclavicular joint, the subacromial bursa and the coracoclavicular/coracoacromial ligaments. It has no cutaneous territory.
• Why the pain is deep and poorly localised. Because its sensory supply is deep, capsular and non-dermatomal, entrapment produces a diffuse, aching, hard-to-point-to posterolateral shoulder pain rather than a sharp, mappable pain — a useful contrast with C5-C6 radiculopathy (which follows a dermatome) in the differential.
• Why the nerve block works. A suprascapular nerve block anaesthetises that large articular territory, which is why it is both diagnostic here (temporary relief supports the diagnosis) and a recognised analgesic tool for shoulder pain more broadly (adhesive capsulitis, post-operative and chronic degenerative or hemiplegic shoulder pain). Ultrasound- or landmark-guided blocks target the nerve in the floor of the suprascapular fossa.
• Corollary: pain can persist after a technically successful decompression if the articular pain generator (the labral tear, capsule) is not also addressed — which is why several series report residual pain.

Early diagnosis matters: once the infraspinatus undergoes chronic fatty infiltration, strength may not fully recover even after successful decompression.

View larger

The topic states repeatedly that chronic fatty atrophy "may not reverse" and that early treatment matters — here is how that atrophy is graded and why it sets the timing of intervention.

• Goutallier grading (originally CT, now applied on the sagittal-oblique "Y" MRI): Grade 0 normal muscle; Grade 1 a few fatty streaks; Grade 2 fat present but less than muscle; Grade 3 fat equal to muscle; Grade 4 fat exceeding muscle. Higher grades reflect irreversible replacement of the denervated infraspinatus (and/or supraspinatus) by fat.
• Supporting measures: the tangent sign (the muscle belly failing to cross a line drawn across the top of the fossa on the Y-view indicates significant atrophy) and the muscle occupation ratio quantify the same process.
• Why it governs timing. Denervated muscle first shows reversible oedema (acute denervation on MRI), then progresses to fatty infiltration and finally fixed atrophy. Once advanced fatty change (Goutallier grade 2-3 or higher) is established, decompression may relieve pain but strength often does not fully recover — the muscle is no longer contractile tissue. This is the mechanistic basis for the "treat early" refrain and for confirming/localising with EMG before atrophy sets in.
• Practical rule: muscle oedema without fatty infiltration on MRI is a favourable, potentially reversible picture; established fatty atrophy predicts incomplete strength recovery and should temper the surgical promise made to the patient.

Other open questions: whether traction neuropathy from a retracted cuff tear needs any direct nerve treatment; the threshold for operating on painless wasting in a high-level athlete; and the lack of a unified outcome metric across small surgical series.

Global Epidemiology

• An uncommon but under-recognised cause of shoulder pain, estimated at roughly 2% of chronic shoulder pain (PMID 25454727).
• Compressive neuropathy is highly prevalent among overhead athletes, but most have no clinically relevant deficit (PMID 32732653).
• Isolated infraspinatus wasting is well described in elite volleyball and other overhead sports, frequently in the dominant arm (PMID 16035699, PMID 29364045).

Side-by-Side Guidance

Across regions the convergent position is that diagnosis rests on EMG/NCS plus MRI, that most cases are managed non-operatively, and that surgery - now predominantly arthroscopic - is reserved for a discrete compressive lesion or refractory symptoms.

Registry & Outcome Notes

• No dedicated international registry exists; evidence rests on RCTs (PMID 34156877), meta-analysis (PMID 35833960), and surgical case series (PMID 33091550, PMID 17210425).
• Arthroscopic decompression series report significant functional improvement and, in the absence of major concomitant pathology, no complications or revisions at medium-term follow-up (PMID 33091550).

High- vs Limited-Resource Practice

• High-resource: routine EMG/NCS, MRI for cyst and labral tear, ultrasound-guided block/aspiration, arthroscopic decompression.
• Limited-resource: clinical pattern recognition and a diagnostic suprascapular nerve block guide management; open decompression under regional anaesthesia remains effective where arthroscopy is unavailable.

Documentation & Consent (universal)

• Record the weakness pattern (supraspinatus vs infraspinatus) and visible wasting at each visit.
• When a cyst is present, document the feeding labral tear and the plan to address it.
• Consent for decompression should include incomplete strength recovery if chronic atrophy exists, cyst recurrence if the labrum is untreated, and risk to the suprascapular nerve and artery.